Oncolytic viruses mediating anti-tumour immunity in human cancer patients
Wednesday, May 19, 2010 - 06:50
in Health & Medicine
The researchers of the University of Helsinki, and Oncos Therapeutics, the biotech company developing new cancer therapeutics based on the next generation oncolytic viruses, published initial results from their Advanced Therapy Access Program in Cancer Research. The therapy program is based on scientific research at the University of Helsinki and serves as the foundation for ongoing clinical development...